Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04876378 · ClinicalTrials.gov registry record
Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 8
- Enrollment target
NCT04876378: Clinical Trial study, sponsored by University of California, San Francisco.
NCT04876378 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04876378 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This study investigates the impact of breast cancer treatment on joint health, cartilage, composition, and bone structure in the knee and hand in patients with hormone-receptor positive stage I-III breast cancer and healthy patients. The investigators will use Magnetic Resonance Imaging (MRI) to assess the quality of hand and knee joints. This study may help doctors learn more about hand and knee joint pain that occurs during aromatase inhibitor treatment.
Primary Outcome
Will determine differences in hyaline cartilage biochemical composition (using magnetic resonance imaging) between breast cancer patients under aromatase inhibitor (AI) treatment. Linear regression models will be used to assess differences in joint parameters outcomes between healthy controls, AI patients with pain, and AI patients without pain (predictors).
Interventions
- PROCEDURE Magnetic Resonance Imaging
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-05-18 |
| Est. Completion | 2022-05-24 |
Why NCT04876378 stopped before completion
NCT04876378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT04876378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04876378 about?
NCT04876378 is a clinical study titled "Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand". This study investigates the impact of breast cancer treatment on joint health, cartilage, composition, and bone structure in the knee and hand in patients with hormone-receptor positive stage I-III breast cancer and healthy patients. The investigators will use Magnetic Resonance Imaging (MRI) to ass...
What is the current status of trial NCT04876378?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2020-05-18. Estimated completion is 2022-05-24.
What interventions are being tested in trial NCT04876378?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04876378?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI